Skip to main content

Table 3 UE-FM subscales outcome measures at end of treatment and at follow-up

From: Counteracting learned non-use in chronic stroke patients with reinforcement-induced movement therapy

Within-group analysis

 

Between-group analysis

Mean (SD) - Median 95 % confidence interval for the mean (lower and upper bound)

 

p-values

 

End of treatment

Change from

p-values

Follow-up

Change from

p-values

Change from

Change from

 

T1

baseline to T1

 

T2

baseline to T2

 

baseline to T1

baseline to T2

Total UE-FM

        

EG

38.33 (17.30) – 39

6.00 (6.31) – 4

.008

46.22 (14.96) – 52

13.89 (9.88) – 10

.004

  
 

[25.04–51.63]

[1.15–10.85]

 

[34.72–57.73]

[6.29–21.48]

   
       

.715

.037

CG

43.22 (12.62) – 44

6.33 (4.50) – 7

.008

41.78 (12.47) – 40

4.89 (4.31) – 5

.016

  
 

[33.52–52.92]

[2.87–9.79]

 

[32.19–51.36]

[1.57–8.20]

   

UE-FM-Proximal

        

EG

21.00 (8.90) – 18

4.00 (3.57) – 4

.016

24.11 (7.67) – 27

7.11 (4.65) – 8

.004

  
 

[10.25–25.75]

[-0.38–7.63]

 

[21.38–32.63]

[-1.01–6.12]

   
       

.619

.420

CG

24.22 (6.50) – 24

5.33 (4.80) – 4

.016

24.33 (7.23) – 24

5.44 (5.30) – 4

.016

  
 

[18.13–29.88]

[-0.75–8.75]

 

[17.62–30.38]

[4.63–11.38]

   

UE-FM-Wrist

        

EG

7.22 (3.31) – 9

1.44 (2.07) – 1

.063

8.33 (2.00) – 9

2.56 (2.35) – 1

.016

  
 

[6.89–11.13]

[0.0–2.0]

 

[7.63–10.38]

[-1.13–3.13]

   
       

.375

.350

CG

5.44 (2.92) – 5

0.67 (1.94) – 0

.500

6.22 (2.77) – 5

1.44 (2.40) – 1

.156

  
 

[3.38–6.63]

[-0.63–0.63]

 

[2.88–7.13]

[-0.75–2.75]

   

UE-FM-Hand

        

EG

8.44 (5.36) – 9

1.00 (2.29) – 0

.250

9.33 (4.64) – 10

1.89 (4.01) – 1

.250

  
 

[5.13–12.88]

[-0.50–0.50]

 

[7.38–12.63]

[-0.25–2.25]

   
       

.116

.055

CG

10.22 (2.63) – 11

-1.22 (3.46) – 0

.500

9.89 (3.79) – 12

-1.56 (3.94) – 0

.313

  
 

[8.50–13.50]

[-0.63–0.63]

 

[9.50–14.50]

[-1.37–1.37]

   

UE-FM-Coordination

        

EG

2.89 (1.83) – 4

0.33 (1.00) – 0

1.000

3.00 (1.94) – 4

0.44 (1.01) – 0

.500

  
 

[2.75–5.25]

[0.00–0.00]

 

[2.63–5.38]

[-1.25–1.25]

   
       

.294

.587

CG

3.22 (1.48) – 3

0.44 (0.53) – 0

.125

3.44 (1.81) – 3

0.67 (1.00) – 0

.125

  
 

[2.38–3.63]

[-0.50–0.50]

 

[1.88–4.13]

[-0.50–0.50]

   
  1. Bold values indicate significant values (p<.05), p-values for within-group analysis were obtained with Wilcoxon signed-rank test, p-values for between-group analysis were obtained with Wilcoxon rank-sum test